Publications by authors named "John D Grabenstein"

Claim this Profile
P
Pharmacists' answer to the COVID-19 pandemic: Contribution of the Federal Retail Pharmacy Program to COVID-19 vaccination across sociodemographic characteristics-United States.
Roua El Kalach, Nkenge H Jones-Jack, John D Grabenstein, Mattie Elam, Abdulhakeem A Olorukooba

J Am Pharm Assoc (2003)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccines against mpox: MVA-BN and LC16m8.
John D Grabenstein, Adam Hacker

Expert Rev Vaccines· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacist assessments and care to improve adult vaccination rates: A report from project IMPACT vaccine confidence.
Benjamin M Bluml, Scott A Hamstra, Lisa L Tonrey, Jonathan B Little, Aaron J Bonham, John D Grabenstein

J Am Pharm Assoc (2003)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Women in pharmacy: Pearls of wisdom from the 2022 inductees and contemporary leaders.
Jennifer M Bingham, John D Grabenstein

J Am Pharm Assoc (2003)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global geotemporal distribution of chikungunya disease, 2011-2022.
John D Grabenstein, Aditya Singh Tomar

Travel Med Infect Dis· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacy on the front lines: A century of pandemic response in America.
Jennifer M Bingham, John D Grabenstein, Sandra Leal, David R Axon

J Am Pharm Assoc (2003)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating risk of bias using ROBINS-I tool in nonrandomized studies of adjuvanted influenza vaccine.
John D Grabenstein, Pietro Ferrara, Lorenzo G Mantovani, Ian McGovern

Vaccine· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of an Innovative Immunization Practice Model to Improve Population Health: Results of the Project IMPACT Immunizations Scaled Demonstration.
Benjamin M Bluml, Kelly A Brock, William R Doucette, John D Grabenstein, Nicole Scovis

Innov Pharm· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Essential services: Quantifying the contributions of America's pharmacists in COVID-19 clinical interventions.
John D Grabenstein

J Am Pharm Assoc (2003)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine humanity.
John D Grabenstein

J Am Pharm Assoc (2003)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remington Honor Medal Address.
John D Grabenstein

J Am Pharm Assoc (2003)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Answering Key Questions About COVID-19 Vaccines.
Jesse L Goodman, John D Grabenstein, M Miles Braun

JAMA· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
outbreaks and implications for transmission and control: a systematic review.
Paul N Zivich, John D Grabenstein, Sylvia I Becker-Dreps, David J Weber

Pneumonia (Nathan)· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination of adults with 23-valent pneumococcal polysaccharide vaccine induces robust antibody responses against pneumococcal serotypes associated with serious clinical outcomes.
Karen L Ciprero, Rocio D Marchese, Patrick Richard, Martine Baudin, Tina M Sterling, John D Grabenstein

Hum Vaccin Immunother· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in the Numbers of US Colleges of Pharmacy and Their Graduates, 1900 to 2014.
John D Grabenstein

Am J Pharm Educ· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of ebola virus disease.
Paul E Kilgore, John D Grabenstein, Abdulbaset M Salim, Michael Rybak

Pharmacotherapy· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interwoven support: an historical survey of US federal programs enabling immunization.
Dack W Dalrymple, John D Grabenstein

Vaccine· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in serious clinical outcomes of infection caused by specific pneumococcal serotypes among adults.
John D Grabenstein, Luwy K Musey

Vaccine· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of pneumococcal vaccines for adults in the United States.
Jieling Chen, Megan A O'Brien, H Keri Yang, John D Grabenstein, Erik J Dasbach

Adv Ther· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pneumococcal serotype diversity among adults in various countries, influenced by pediatric pneumococcal vaccination uptake.
John D Grabenstein, David J Weber

Clin Infect Dis· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What the world's religions teach, applied to vaccines and immune globulins.
John D Grabenstein

Vaccine· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of adult pneumococcal vaccination: responding to: Weycker D, Sato R, Strutton D, Edelsberg J, Atwood M, Jackson LA. Public health and economic impact of 13-valent pneumococcal conjugate vaccine in US adults aged ≥50 years. Vaccine 2012;30(August (36)):5437-44.
John D Grabenstein, Megan A O'Brien, Jieling Chen

Vaccine· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and serotype coverage: key criteria for pneumococcal vaccines for adults.
John D Grabenstein

Clin Infect Dis· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pneumococcal polysaccharide 23-valent vaccine: long-term persistence of circulating antibody and immunogenicity and safety after revaccination in adults.
John D Grabenstein, Susan B Manoff

Vaccine· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pneumococcal vaccines in adults: assessing the evolving evidence.
John D Grabenstein, Susan B Manoff

Vaccine· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis